Cardiometabolic index as a novel prognostic biomarker for cardiovascular events in post-percutaneous coronary intervention patients with ST-segment elevation myocardial infarction: two-center retrospective study
Elevated CMI is positively associated with MACEs and rehospitalization for heart failure in STEMI patients, with partial mediation through inflammatory pathways. CMI may thus be a valuable prognostic tool for this patient group.
Authors
- Ke Chen (ORCID: https://orcid.org/0000-0001-5310-5090)
- Gangyong Wu (ORCID: https://orcid.org/0000-0003-3310-6488)
- Yan Liu (ORCID: https://orcid.org/0000-0001-8517-1084)
- Yehong Liu (ORCID: https://orcid.org/0000-0002-1211-2961)
- Gang‐Jun Zong (ORCID: https://orcid.org/0000-0002-9119-0705)
- Liu Longqun
Institutions
- Xuzhou Medical College (CN)
- 81th Hospital of PLA (CN)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/03007995.2025.2605695
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00